Watchlist Price Alert

MultiPlan Corporation (MPLN)

NYSE: MPLN · Real-Time Price · USD

23.15

-0.36 (-1.53%)

At close: Feb 27, 2025, 3:59 PM

-1.53% (1D)

Bid	21.55
Market Cap	374.98M
Revenue (ttm)	930.62M
Net Income (ttm)	-1.65B
EPS (ttm)	-101.92
PE Ratio (ttm)	-0.22713893249607536
Forward PE	-2.17
Analyst	Hold

Ask	24.09
Volume	204,844
Avg. Volume (20D)	207,985
Open	23.99
Previous Close	23.51
Day's Range	22.77 - 24.99
52-Week Range	4.80 - 38.49
Beta	0.33

About MPLN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MPLN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MPLN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

MultiPlan has released their quartely earnings on Feb 25, 2025:

Revenue of $232.15M misses estimates by $2.63M, with -4.91% YoY decline.

EPS of -5.16 misses estimates by -2.83, with -158.00% YoY decline.

Next Earnings Release

MultiPlan Corporation is scheduled to release its earnings on May 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

MultiPlan shares are trading lower following a Q4 ... Unlock content with Pro Subscription

7 months ago

MultiPlan shares are trading lower after Citigroup cut its price target on the stock from $17.2 to $10.

News

2 months ago · businesswire.com

ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks

SAN DIEGO--(BUSINESS WIRE)-- #5hmC--ClearNote Health's Avantect Pancreatic Cancer Test will now be available to members accessing Claritev's national PHCS and MultiPlan Networks.

2 months ago · seekingalpha.com

Claritev Corporation (MPLN) Q4 2024 Earnings Call Transcript

2 months ago · zacks.com

MultiPlan Corporation (MPLN) Reports Q4 Loss, Misses Revenue Estimates

MultiPlan Corporation (MPLN) came out with a quarterly loss of $5.14 per share versus the Zacks Consensus Estimate of a loss of $2.33. This compares to loss of $2.40 per share a year ago.

2 months ago · businesswire.com

Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

NEW YORK--(BUSINESS WIRE)--Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025.

2 months ago · businesswire.com

Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design

NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--Claritev Corporation (“Claritev” or the “Company”) (NYSE: MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healt...

2 months ago · businesswire.com

MultiPlan Enters New Era and Unveils New Brand, Claritev, Reflecting Company's Transformation and Mission to Support the Healthcare Continuum

NEW YORK--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affor...

3 months ago · businesswire.com

MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

NEW YORK--(BUSINESS WIRE)--MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call.

3 months ago · businesswire.com

MultiPlan Announces Expiration and Results of Exchange Offers and Consent Solicitations for Outstanding Notes and Term Loans with Over 99% Participation of Existing Noteholders and Lenders

NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading provider of technology and data solutions focused on cost management, improving ...